R. Danny Huntington at FICPI ExCo Meeting 2024 on Artificial Intelligence and Patenting Pharmaceuticals
Partner R. Danny Huntington will be a panelist at the workshop "AI and Patenting Pharmaceuticals" during the Fédération Internationale des Conseils en Propriété Intellectuelle (FICPI) Executive Committee (ExCo) Meeting held March 17-20, 2024, in Goa, India. Danny's workshop will be held on Monday, March 18.
As part of a workshop on AI and Patenting of Pharmaceuticals, Danny will provide a description of how Artificial Intelligence (AI) is used in the discovery of new small molecules and biologics, and the various recent materials from the U.S. Patent and Trademark Office After his presentation, the workshop will focus on the effect of libraries of virtual compounds on patentability. The discussion will include various topics, including issues relating to utility and enablement, the need for testing of virtual compounds, whether the use of AI needs to be disclosed to the relevant patent office, and whether AI could ever replace animal/human testing as proof of effects (good and bad).
FICPI is the only international NGO whose membership consists exclusively of IP attorneys in private practice. As a result, the FICPI community is driven by a shared interest to promote solutions and advocacy for private IP practitioners.
